178 related articles for article (PubMed ID: 7731707)
1. Proto-oncogenic properties of the DP family of proteins.
Jooss K; Lam EW; Bybee A; Girling R; Müller R; La Thangue NB
Oncogene; 1995 Apr; 10(8):1529-36. PubMed ID: 7731707
[TBL] [Abstract][Full Text] [Related]
2. A new member of the DP family, DP-3, with distinct protein products suggests a regulatory role for alternative splicing in the cell cycle transcription factor DRTF1/E2F.
Ormondroyd E; de la Luna S; La Thangue NB
Oncogene; 1995 Oct; 11(8):1437-46. PubMed ID: 7478568
[TBL] [Abstract][Full Text] [Related]
3. Integration of a growth-suppressing BTB/POZ domain protein with the DP component of the E2F transcription factor.
de la Luna S; Allen KE; Mason SL; La Thangue NB
EMBO J; 1999 Jan; 18(1):212-28. PubMed ID: 9878064
[TBL] [Abstract][Full Text] [Related]
4. Association with E2F-1 governs intracellular trafficking and polyubiquitination of DP-1.
Magae J; Illenye S; Chang YC; Mitsui Y; Heintz NH
Oncogene; 1999 Jan; 18(3):593-605. PubMed ID: 9989809
[TBL] [Abstract][Full Text] [Related]
5. Functional interplay between p53 and E2F through co-activator p300.
Lee CW; Sørensen TS; Shikama N; La Thangue NB
Oncogene; 1998 May; 16(21):2695-710. PubMed ID: 9652736
[TBL] [Abstract][Full Text] [Related]
6. The molecular basis of E2F-1/DP-1-induced S-phase entry and apoptosis.
Shan B; Farmer AA; Lee WH
Cell Growth Differ; 1996 Jun; 7(6):689-97. PubMed ID: 8780882
[TBL] [Abstract][Full Text] [Related]
7. A new component of the transcription factor DRTF1/E2F.
Girling R; Partridge JF; Bandara LR; Burden N; Totty NF; Hsuan JJ; La Thangue NB
Nature; 1993 Mar; 362(6415):83-7. PubMed ID: 8446173
[TBL] [Abstract][Full Text] [Related]
8. Isolation and characterization of a chicken homolog of the E2F-1 transcription factor.
Pasteau S; Loiseau L; Arnaud L; Trembleau A; Brun G
Oncogene; 1995 Oct; 11(8):1475-86. PubMed ID: 7478572
[TBL] [Abstract][Full Text] [Related]
9. Transcription factors of the Sp1 family: interaction with E2F and regulation of the murine thymidine kinase promoter.
Rotheneder H; Geymayer S; Haidweger E
J Mol Biol; 1999 Nov; 293(5):1005-15. PubMed ID: 10547281
[TBL] [Abstract][Full Text] [Related]
10. Adenovirus E4 open reading frame 4-induced dephosphorylation inhibits E1A activation of the E2 promoter and E2F-1-mediated transactivation independently of the retinoblastoma tumor suppressor protein.
Mannervik M; Fan S; Ström AC; Helin K; Akusjärvi G
Virology; 1999 Apr; 256(2):313-21. PubMed ID: 10191196
[TBL] [Abstract][Full Text] [Related]
11. E2F-dependent regulation of human MYC: trans-activation by cyclins D1 and A overrides tumour suppressor protein functions.
Oswald F; Lovec H; Möröy T; Lipp M
Oncogene; 1994 Jul; 9(7):2029-36. PubMed ID: 8208548
[TBL] [Abstract][Full Text] [Related]
12. A novel E2F binding protein with Myc-type HLH motif stimulates E2F-dependent transcription by forming a heterodimer.
Suzuki M; Okuyama S; Okamoto S; Shirasuna K; Nakajima T; Hachiya T; Nojima H; Sekiya S; Oda K
Oncogene; 1998 Aug; 17(7):853-65. PubMed ID: 9780002
[TBL] [Abstract][Full Text] [Related]
13. Transcriptional control by E2F.
Adams PD; Kaelin WG
Semin Cancer Biol; 1995 Apr; 6(2):99-108. PubMed ID: 7647312
[TBL] [Abstract][Full Text] [Related]
14. Molecular and functional characterisation of E2F-5, a new member of the E2F family.
Buck V; Allen KE; Sørensen T; Bybee A; Hijmans EM; Voorhoeve PM; Bernards R; La Thangue NB
Oncogene; 1995 Jul; 11(1):31-8. PubMed ID: 7542760
[TBL] [Abstract][Full Text] [Related]
15. Molecular characterization of Xenopus laevis DP proteins.
Girling R; Bandara LR; Ormondroyd E; Lam EW; Kotecha S; Mohun T; La Thangue NB
Mol Biol Cell; 1994 Oct; 5(10):1081-92. PubMed ID: 7865876
[TBL] [Abstract][Full Text] [Related]
16. Down-regulation of cyclin A gene expression upon genotoxic stress correlates with reduced binding of free E2F to the promoter.
Spitkovsky D; Schulze A; Boye B; Jansen-Dürr P
Cell Growth Differ; 1997 Jun; 8(6):699-710. PubMed ID: 9186003
[TBL] [Abstract][Full Text] [Related]
17. Structural characterization and specificity of expression of E2F-5: a new member of the E2F family of transcription factors.
Itoh A; Levinson SF; Morita T; Kourembanas S; Brody JS; Mitsialis SA
Cell Mol Biol Res; 1995; 41(3):147-54. PubMed ID: 8589754
[TBL] [Abstract][Full Text] [Related]
18. Dual control of myc expression through a single DNA binding site targeted by ets family proteins and E2F-1.
Roussel MF; Davis JN; Cleveland JL; Ghysdael J; Hiebert SW
Oncogene; 1994 Feb; 9(2):405-15. PubMed ID: 8290253
[TBL] [Abstract][Full Text] [Related]
19. Exogenous E2F expression is growth inhibitory before, during, and after cellular transformation.
Lee TA; Farnham PJ
Oncogene; 2000 Apr; 19(18):2257-68. PubMed ID: 10822376
[TBL] [Abstract][Full Text] [Related]
20. BRCA1 proteins are transported to the nucleus in the absence of serum and splice variants BRCA1a, BRCA1b are tyrosine phosphoproteins that associate with E2F, cyclins and cyclin dependent kinases.
Wang H; Shao N; Ding QM; Cui J; Reddy ES; Rao VN
Oncogene; 1997 Jul; 15(2):143-57. PubMed ID: 9244350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
